OGEN ▲ +7.5% - Oragenics, Inc. $OGEN - Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update Oragenics shares gained 7.5% following the company's announcement of continued clinical progress and updates regarding regulatory matters and its NYSE American listing status. The clinical advancement, combined with news about maintaining its NYSE American listing, likely boosted investor confidence in the company's progress and market standing. No specific clinical trial results or regulatory milestones were detailed in the headline, but the combination of operational updates and listing confirmation appears to have driven the positive market reaction. 28-AUG-2026 04:25 PM ET